Business · 31/03/2005Updated: 10/17/2026 · 1 min read
FDA Cancels Meeting of Cardiovascular and Renal Drugs Advisory Committee
Summary
The US Food and Drug Administration (FDA) has cancelled a meeting of the Cardiovascular and Renal Drugs Advisory Committee, originally scheduled for April 5, 2005, after it was announced in the Federal Register on March 9, 2005 (70 FR 11678).
Original source language: Federal Register — Food and Drug AdministrationOpen original release →